[go: up one dir, main page]

UA85685C2 - Применение хинолоновых антибиотиков для лечения бактериальных заболеваний ротовой полости - Google Patents

Применение хинолоновых антибиотиков для лечения бактериальных заболеваний ротовой полости

Info

Publication number
UA85685C2
UA85685C2 UAA200602704A UAA200602704A UA85685C2 UA 85685 C2 UA85685 C2 UA 85685C2 UA A200602704 A UAA200602704 A UA A200602704A UA A200602704 A UAA200602704 A UA A200602704A UA 85685 C2 UA85685 C2 UA 85685C2
Authority
UA
Ukraine
Prior art keywords
oral cavity
bacterial diseases
quinolone antibiotics
controlling bacterial
antibiotics
Prior art date
Application number
UAA200602704A
Other languages
English (en)
Ukrainian (uk)
Inventor
Герт Даубе
Маркус Эдингло
Бернд Штефан
Франц Пирро
Агнесс Лиме
Original Assignee
Байер Хелскер Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34201505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA85685(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Байер Хелскер Аг filed Critical Байер Хелскер Аг
Publication of UA85685C2 publication Critical patent/UA85685C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к применению 8-цианохинолоновых антибиотиков для получения лекарственных средств для лечения бактериальных заболеваний ротовой полости, в частности в ветеринарии.
UAA200602704A 2003-08-13 2004-08-02 Применение хинолоновых антибиотиков для лечения бактериальных заболеваний ротовой полости UA85685C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10337191A DE10337191A1 (de) 2003-08-13 2003-08-13 Neue Verwendung von Chinolon-Antibiotika

Publications (1)

Publication Number Publication Date
UA85685C2 true UA85685C2 (ru) 2009-02-25

Family

ID=34201505

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200602704A UA85685C2 (ru) 2003-08-13 2004-08-02 Применение хинолоновых антибиотиков для лечения бактериальных заболеваний ротовой полости

Country Status (32)

Country Link
US (1) US8658645B2 (ru)
EP (1) EP1656143B1 (ru)
JP (2) JP5122814B2 (ru)
KR (1) KR101209119B1 (ru)
CN (1) CN100571702C (ru)
AR (2) AR045093A1 (ru)
AT (1) ATE528004T1 (ru)
AU (2) AU2004266452A1 (ru)
BR (1) BRPI0413509A (ru)
CA (1) CA2535637C (ru)
CY (1) CY1112167T1 (ru)
DE (1) DE10337191A1 (ru)
DK (1) DK1656143T3 (ru)
ES (1) ES2374728T3 (ru)
GT (1) GT200400156A (ru)
HR (1) HRP20120019T1 (ru)
IL (1) IL173655A (ru)
LU (1) LU91883I2 (ru)
MX (1) MXPA06001597A (ru)
MY (1) MY162652A (ru)
NO (1) NO333116B1 (ru)
NZ (1) NZ545261A (ru)
PE (1) PE20050341A1 (ru)
PL (1) PL1656143T3 (ru)
PT (1) PT1656143E (ru)
RU (1) RU2367437C2 (ru)
SI (1) SI1656143T1 (ru)
TW (1) TWI367095B (ru)
UA (1) UA85685C2 (ru)
UY (1) UY28465A1 (ru)
WO (1) WO2005018641A2 (ru)
ZA (1) ZA200601167B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
TW200510425A (en) * 2003-08-13 2005-03-16 Japan Tobacco Inc Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
FR2896416B1 (fr) * 2006-01-24 2010-08-13 Vetoquinol Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
WO2010069493A1 (de) * 2008-12-18 2010-06-24 Bayer Animal Health Gmbh Verbesserte wirkstoffkombination enthaltend ein antibiotikum und einen nichtsteroidalen entzündungshemmer (nsaid)
CN102988280B (zh) * 2012-10-08 2014-03-19 新乡医学院 一种加雷沙星滴眼剂
JP6358868B2 (ja) * 2014-06-17 2018-07-18 Ｄｓファーマアニマルヘルス株式会社 オルビフロキサシンを含有する製剤組成物
CN106831795B (zh) * 2017-01-16 2018-12-21 石家庄学院 喹诺酮异土木香内酯衍生物及其制备和应用
PE20201257A1 (es) 2018-04-25 2020-11-16 Bayer Animal Health Gmbh Proceso para la hidrolisis de esteres carboxilicos de quinolona
BR112022010112A2 (pt) * 2019-11-28 2022-09-06 Bayer Ag Aminoquinolonas substituídas como inibidores de dgkalfa para ativação imunológica

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62205060A (ja) * 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd ８位置換キノロンカルボン酸誘導体
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
CN1100053C (zh) * 1996-02-09 2003-01-29 富山化学工业株式会社 喹诺酮羧酸衍生物或它们的盐类
WO1997031001A1 (de) 1996-02-23 1997-08-28 Bayer Aktiengesellschaft Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate
TW415943B (en) * 1996-06-28 2000-12-21 Bayer Ag 7-(3-vinyl-1,4-piperazin-1-yl)-substituted quinolonecarboxylic acids
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
DE19652219A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
AU3952397A (en) * 1997-08-22 1999-03-16 Dainippon Pharmaceutical Co. Ltd. Pyridonecarboxylic acid derivatives and intermediates for the preparation thereof
WO2000027398A1 (de) * 1998-11-10 2000-05-18 Bayer Aktiengesellschaft Pharmazeutische zubereitung von moxifloxacin
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika

Also Published As

Publication number Publication date
BRPI0413509A (pt) 2006-10-10
RU2367437C2 (ru) 2009-09-20
EP1656143A2 (de) 2006-05-17
DE10337191A1 (de) 2005-03-17
AR045093A1 (es) 2005-10-12
TWI367095B (en) 2012-07-01
AU2004266452A1 (en) 2005-03-03
WO2005018641A3 (de) 2005-10-06
KR20060061353A (ko) 2006-06-07
IL173655A0 (en) 2006-07-05
ZA200601167B (en) 2007-04-25
GT200400156A (es) 2005-03-23
WO2005018641A2 (de) 2005-03-03
AU2011200356B2 (en) 2012-01-12
TW200517110A (en) 2005-06-01
KR101209119B1 (ko) 2012-12-07
PT1656143E (pt) 2012-01-12
PL1656143T3 (pl) 2012-03-30
CN1867335A (zh) 2006-11-22
RU2006107497A (ru) 2006-08-10
CN100571702C (zh) 2009-12-23
AU2011200356A1 (en) 2011-02-17
SI1656143T1 (sl) 2012-03-30
ATE528004T1 (de) 2011-10-15
CA2535637A1 (en) 2005-03-03
US8658645B2 (en) 2014-02-25
JP2012211170A (ja) 2012-11-01
NZ545261A (en) 2009-11-27
JP2007501819A (ja) 2007-02-01
MXPA06001597A (es) 2006-05-19
CA2535637C (en) 2011-11-08
MY162652A (en) 2017-06-30
US20070082911A1 (en) 2007-04-12
LU91883I2 (fr) 2013-04-12
AR109644A2 (es) 2019-01-09
JP5122814B2 (ja) 2013-01-16
NO20061127L (no) 2006-03-08
UY28465A1 (es) 2005-03-31
IL173655A (en) 2013-07-31
HK1098687A1 (zh) 2007-07-27
NO333116B1 (no) 2013-03-04
ES2374728T3 (es) 2012-02-21
CY1112167T1 (el) 2015-12-09
EP1656143B1 (de) 2011-10-12
PE20050341A1 (es) 2005-07-07
DK1656143T3 (da) 2012-02-06
HRP20120019T1 (hr) 2012-02-29

Similar Documents

Publication Publication Date Title
CY1112167T1 (el) Νεα χρηση αντιβιοτικων κινολονης
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
EP1638938A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING ORTHOPOXVIRUS INFECTIONS AND RELATED DISEASES
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
TW200510449A (en) Acylated nonadepsipeptides
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
AP2005003375A0 (en) Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them.
WO2005030109A3 (en) Regimen for the administration of rifamycin-class antibiotics
ATE401074T1 (de) Synergistische antibakterielle formulierung und herstellungsmethode
TW200517144A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
IL194353A0 (en) Lysobactin amides
TW200621799A (en) Acylated nonadepsipeptides II
PL371524A1 (en) Combination therapy for the treatment of bacterial infections
TWI347845B (en) Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same
AU2003210850A1 (en) N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
AP2006003613A0 (en) Oral formulations for 5-HT-receptor agonists, usesand methods of treatment employing the same
ATE433459T1 (de) Desoxo-nonadepsipeptide
DE502005010850D1 (de) Antibakterielle amid-makrozyklen iv
WO2005118613A3 (de) Antibakterielle amid-makrozyklen
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
ATE455789T1 (de) Substituierte nonadepsipeptide
AU2003279247A1 (en) The use of bacterial phage associated lysing proteins for treating bacterial dental caries
MD2551G2 (ru) Использование фармацевтически-приемлемых озонированных растворов для лечения грибковых заболеваний ротовой полости
MY140242A (en) BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS
AU2002950363A0 (en) Veterinary oral treatment composition